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Gene expression of interleukin-113 during hemodialysis. It is still
controversial whether the hemodialysis (HD) procedure is an inflam-
matory process in vivo. Therefore, we studied the gene expression of
interleukin-113 (IL-l/3) as a marker of inflammation in peripheral blood
mononuclear cells (PBMC) of patients during HD by Northern blotting
and polymerase chain reaction. Compared to PBMC separated pre-HD
(1.0 densitometric units), the amount of IL-1f3 mRNA was increased in
PBMC leaving the dialyzer (12.2 2densitometric units, P < 0.01), but
was not increased in PBMC re-entering the dialyzer from the systemic
circulation (0.6 0.1 densitometric units) in all 12 patients studied. The
maximal amount of IL-lf3 mRNA in PBMC was seen at five minutes
after start of HD. There was a significant correlation between the
increase in IL-1f3 mRNA and the increase in activated complement C5a(r = 0.71, P < 0.01). HD using less complement-activating membranes
(hemophan, polysulfone, polyamide or polyacrylonitrile) resulted in no
detectable IL-1/3 mRNA. Furthermore, a monoclonal antibody against
human C5a reduced the increase in IL-lfl mRNA by 83% (P < 0.05),
indicating that C5a plays a major role for induction of IL-lp mRNA
during HD. This study demonstrates that during HD with regenerated
cellulose, gene expression for IL-1/3 takes place in PBMC.
It has been suggested that induction of IL-i during HD
contributes to many of the pathological changes associated with
HD therapy including dialysis related amyloidosis and protein
catabolism [1—4]. In the past several years, there have been a
number of studies investigating the induction of cytokines
during HD. In vitro studies have demonstrated possible mech-
anisms of cytokine induction: cytokine-inducing substances are
capable of penetrating an intact dialyzer from the dialysate into
the blood compartment [5]; complement factors generated
during in vitro HD induce transcription rather than translation
of IL-i [6]; a direct stimulatory effect of cellulose on cytokine
production has been reported [7]. In vivo evidence supporting
this hypothesis has been more difficult to obtain. Cell-associ-
ated levels of IL-I in non-incubated PBMC from HD patients
have been found to be elevated compared to normals [8, 9].
However, one study reported elevated cell-associated levels of
IL-I bioactivity even in uremic patients not on renal replace-
ment therapy [8] while the other study did not confirm this
finding [9]. Therefore, it is possible that increased cell-associ-
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ated levels of IL-i are influenced not only by the dialysis
procedure itself but also by not dialysis-related factors. Mea-
surement of cytokines in plasma or serum in HD patients gave
conflicting results. While some studies reported elevated circu-
lating levels of IL-i in patients compared to normal subjects
[10—12], other studies did not confirm these results [13—16].
Furthermore, in most studies there was no or only a small rise
in circulating IL-i levels during HD [13—17]. A possible expla-
nation for the difficulties to detect cytokines in the circulation is
the variety of inhibitors and binding proteins present in plasma,
which may also be produced in cell culture supernatants. For
instance, a TNFa binding protein purified from the urine of HD
patients and normal subjects was described that interferes with
immunoassays for TNF [18]. This TNF binding protein proba-
bly reflects the soluble form of the TNF receptor. In the case of
IL-i, the recently described IL-i receptor antagonist [19],
soluble IL-i receptors [20], auto-antibodies [21] or non-specific
binding proteins [22] may account for the failure to detect IL-i
in the circulation of patients on regular dialysis treatment. In
addition, plasma levels of IL-i are influenced by renal function
since animal studies demonstrated that the kidney is the major
organ by which IL-i is excreted [23]. Therefore, in the present
study, we investigated gene expression of IL-1f3 in PBMC
during HD as a possible early and sensitive marker of cell
activation.
Methods
Patients
Studies on IL-i 13 gene expression were performed on 29
stable end-stage renal disease patients on routine HD three
times for four to five hours a week. Patients had not had a
recent infection or a febrile illness, nor were they being treated
with immunosuppressive drugs. Sixteen patients were dialyzed
with regenerated cellulosic dialyzers only (GFS 15H, Gambro,
Sweden); 13 patients were dialyzed with a regenerated cellulo-
sic dialyzer first, and during the consecutive HD session they
were dialyzed using either hemophan (GFS 12 plus, Gambro, N
= 3); polyamide (Polyflux, Gambro, N = 4), polysulfone (F60,
Fresenius, Bad Homburg, Germany, N 3) or polyacrylonitrile
dialyzers (AN69, Filtral 16, Hospal, France, N = 3). HD was
performed using bicarbonate dialysate containing between
<0.15 and 1.5 IEU/ml endotoxin (EC-5 standard) as determined
by Limulus Amebocyte Lysate Test (Pyrogent®, Byk-Sangtec,
Germany). Eleven apparently healthy subjects from laboratory
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Fig. 1. Effect of incubation time of whole blood on expression of JL -1 /3 mRNA. Blood was drawn from a normal subject as well as from the arterial
fistula of a patient before start of HD (pre) or from the venous outlet of the dialyzer at 5 minutes after start of HD (5' eff. blood). Whole blood was
incubated for the indicated time periods at 37°C in 5% CO2. PBMC were separated and RNA was extracted for Northern analysis without further
incubation. LPS denotes PBMC stimulated with 10 ng/ml LPS for 4 hours as a positive control.
personnel served as controls. Plasma C5a levels were deter-
mined in 18 patients on regenerated cellulose, 5 patients on
hemophan, 7 patients on polyamide, 7 patients on polysulfone
and 15 normal subjects.
Separation of mononuclear cells and RNA extraction
Blood was drawn from the afferent or efferent blood tubings
at the indicated time points during HD into heparinized syringes
(5 U/ml). In initial experiments we found that a 30-minute
incubation period of whole blood is necessary and sufficient for
detection of IL-l/3 mRNA. All samples were therefore incu-
bated for 30 minutes at 37°C in sterile, pyrogen-free 50 ml
polypropylene tubes (Greiner, Germany) in a humidified atmo-
sphere containing 5% CO2. PBMC were separated from whole
blood after the 30 minute incubation by centrifugation through
FicolllHypaque made from powder using ultrafiltered water
(Ficoll Type 400; sodium- and meglumine diatrizoate, Sigma,
Munich, Germany). The distilled water as well as the cell
culture medium was subjected to ultrafiltration using polyamide
filters (U 2000, Gambro) to remove cytokine-inducing sub-
stances [24]. Differential counts were performed on cytospins
by Pappenheim's stain and staining for esterase (Sigma). After
two washes with saline, PBMC were lysed immediately after
separation from whole blood in 4 M guanidine isothiocyanate
solution [25]. Total RNA was extracted by centrifugation
through 5.7 M cesium chloride (Paesel, Frankfurt, Germany),
quantitated by determining optical density at 260 and 280 nm
and precipitated in ethanol.
In four experiments, whole blood from normal donors was
incubated at 37°C with or without 30 ng/ml recombinant C5a
(Sigma). After a two-minute incubation period, RPMI was
added to one sample to dilute the C5a concentration to 5 nglml
Fig. 2. Relative amounts for IL-I/3 mRNA in normal controls and HD
patients dialyzed with regenerated cellulose. Blood was drawn from
normal subjects or from HD patients and incubated for 30 minutes at
37°C cx vivo. PBMC were separated, RNA was extracted without
further incubation and 10 rig/lane was subjected to Northern analysis.
Northern blots were performed and the specific bands for IL-113 mRNA
were quantitated by two-dimensional densitonietry. Data are expressed
in relative densitometric units; densitometric units for normal subjects
(A) and for patients pre HD (B) were assigned a value of 1.0. Only
samples on the same autoradiograph were compared to each other.
<0.01 (Wilcoxon signed-rank test); NS not significant (Mann-Whitney
test).
for the remaining 28 minutes of incubation. Then PBMC were
separated and RNA was extracted as described above.
Northern analysis
Agarose gel electrophoresis, nucleic acid transfer, hybridiza-
tion and autoradiography were performed using standard tech-
niques [25]. Loading of equal amounts of total RNA per lane
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Fig. 3. Accumulation of IL-i/3 mRNA during
HD. Blood was drawn at the indicated time
points during HD from the afferent (aff.) or
efferent (eff.) blood line of the dialyzer and
processed as described in Fig. 2. Levels of
C5a determined in the same samples are
indicated below the corresponding lanes.
Normal denotes blood from a normal subject
incubated for 30 minutes at 37°C. The same
blot was hybridized for 13-actin to ensure
equal loading of total RNA per lane. The
figure shows one representative out of four
experiments with different patients.
(usually 10 g) was confirmed by staining the RNA with
ethidium bromide. The IL-l/3 probe was a 1075 bp fragment (bp
279 to bp 1354 of the full length cDNA) of the IL-l$ precursor
subcloned in pGEM2 [26]. The DNA was labeled with 32P-
dCTP by use of a random primer DNA labeling kit (Boehringer
Mannheim, Mannheim, Germany). As a control, blots were
hybridized with a 13-actin cDNA. Autoradiographs were
scanned using a video camera assisted scanner (Cybertech CS 1,
Berlin, Germany) by two-dimensional densitometry; the densi-
tometric units of the lane corresponding to the pre-HD sample
was assigned a value of 1.0. Thus, the amount of IL-1f3 mRNA
at different time points during HD was compared to the amount
present in the pre-HD sample of the same patient. In experi-
ments comparing normal subjects and patients, the IL-13 band
for the normal control was assigned a value of 1.0. Only
samples on the same autoradiograph were compared to each
other to eliminate differences in background hybridization.
Polymerase chain reaction (PCR)
PBMC were separated and RNA was extracted as described
above, 1 tg RNA was reverse transcribed into cDNA by using
random hexamers and AMY reverse transcriptase (both Boeh-
ringer) and lx PCR buffer (20 m Tris-HC1, pH 8.3; 50 mr'i
KC1; 2 m MgCI; 100 jsg/ml bovine serum albumin). Two
hundred and fifty ng cDNA were amplified by PCR in a total
volume of 60 1d using 2.5 U Ampli-Taq DNA-polymerase
(Perkin Elmer-Cetus), 50 MdNTPs (Boehringer) and 0.5 Mof
each primer in 1 x PCR buffer. Cycles included one minute each
at 95°C, 60°C and 72°C in a microprocessor-driven thermal
cycler (Fa. Landgraf, Hannover, Germany). Primers for IL-1f3
were: 5'-AAA CAG ATG AAG TGC TCC TFC CAG G and
TGG AGA ACA CCA CTT GrF GCT CCA-2'. Primers for
/3-actin were: 5'-ATG GAT GAT GAT ATC GCC GCG and
CTA GAA GCA m GCG GTG GAC GAT GGA GGG CC-3'.
For semiquantitative analysis of mRNA, the kinetics of the
PCR reaction were monitored; the number of cycles at which
the PCR products became detectable on the gel was compared
between the different samples [27]. Aliquots (10 l) were taken
after different numbers of cycles, analyzed on 1.5% agarose gels
and the PCR products were stained with ethidium bromide. In
initial experiments, serial 10-fold dilutions of cDNA (100, 10
and 1 ng) were amplified. The PCR products became detectable
at earlier cycles with increasing amounts of cDNA. A 10-fold
higher amount of cDNA resulted in detection of the PCR
products four cycles earlier; thus, the amplification efficiency of
the PCR was 1.8 per cycle for both IL-lj3 and /3-actin. This
semiquantitative approach for estimating different amounts of
mRNA was also validated by comparison to Northern blotting
using RNA from PBMC stimulated with different amounts of
LPS (data not shown). There was a good agreement between
the two methods in two different experiments. PCR for /3-actin
. .
a
Fig. 4. PCR analysis of IL-i /3 mRNA during
HD using regenerated cellulose in two
different patients. Blood was drawn at the
indicated time points after start of HD and
processed as described for Fig. 2. One
microgram of total RNA was reverse
transcribed into cDNA and 250 ng cDNA
were amplified using primers for fI-actin and
IL-1/3. Aliquots were taken after the indicated
numbers of cycles (every 2 cycles) and
analyzed on 1.5% agarose gels. PCR products
were stained with ethidium bromide. Shown
are results from two different patients.
Analysis of the amplification products for /3-
actin showed similar amounts of /3-actin
mRNA in all samples.
was performed to ensure equal amounts of total RNA in all
samples.
ELISA for C5a
For determination of C5a, 2 ml of blood was drawn into 20
mM EDTA and 10 m benzamidine, centrifuged at 4°C, and the
plasma was then stored at —70°C. C5a was measured by ELISA
without previous precipitation of C5 [28] using two different
monoclonal antibodies against C5a and recombinant human C5a
(Sigma) as the standard. Piasmas were measured at a 1:10, 1:20,
1:40 and 1:80 dilution. The detection limit of the ELISA varied
between 50 and 100 pg/mi; thus, C5a plasma levels above 0.5 to
1.0 ng/ml could be detected.
Statistical analysis
Data are expressed as means standard error of the mean
(sEM). Comparisons were performed using non-parametric tests
as indicated (Wilcoxon signed rank test for paired data, Mann-
Whitney test for unpaired data and Spearman rank correlation
analysis).
Results
Expression of IL-i /3 mRNA during HD with regenerated
cellulosic dialyzers
When blood was drawn from two normal donors and incu-
bated for 30, 60 or 90 minutes at 37°C, IL-1/3 mRNA in PBMC
was just detectable by Northern blotting (Fig. 1). PBMC drawn
pre-HD did not express increased levels of IL-l/3 mRNA
compared to normals. Cells separated from whole blood drawn
from the efferent line five minutes after the start of HD from a
patient on regenerated cellulose showed marked accumulation
of IL-l/3 mRNA (Fig. 1). Accumulation of IL-l/3 mRNA was
observed even without ex vivo incubation and increased after 30
minutes of incubation time of whole blood. Since levels of
IL-1/3 mRNA did not substantially increase after longer incu-
bation times of 60 and 90 minutes, subsequently all samples
were incubated for 30 minutes. When whole blood from normal
subjects was exposed to 30 ng/ml recombinant C5a for only two
minutes before C5a was diluted to 5 ng/ml for the rest of the
30-minute incubation period, induction of IL-l/3 mRNA was
also observed, although less than when 30 nglml C5a was
present for the whole incubation period (data not shown).
When IL-i /3 mRNA levels in PBMC from 11 normal subjects
and patients pre-HD were compared (Fig. 2A), no significant
difference was observed (1.0 vs. 1.7 0.4 densitometric units;
P = 0.2, Mann-Whitney test). In 12 patients on regenerated
cellulose (Fig. 2B), there was an increase in IL-l/3 mRNA
accumulation in cells drawn at five minutes from the efferent
blood line (12.2 2 densitometric units; P < 0.01, Wiicoxon
signed rank test).
In four other patients blood was also drawn at 5 and 180
minutes after start of HD from the afferent and efferent blood
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5 mm aff.
5 mm elf.
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15 mm elf.
60 mm aft.
60 mm elf.
1lines. One representative experiment is shown in Figure 3. Cells
isolated from blood drawn from the venous, efferent blood line
five minutes after the start of dialysis expressed marked in-
creased amounts of IL-1f3 mRNA compared to pre-HD. A
smaller increase in IL-l/3 mRNA was observed in cells drawn
180 minutes after start of dialysis from the efferent bloodline. In
blood drawn from the afferent blood line, mRNA for IL-1f3 was
barely detectable at all three time points (pre, 5 and 180 mm).
Determination of C5a at the same time points revealed the
highest levels of C5a in the sample with the highest level of
IL-113 mRNA (Fig. 3).
Analysis of IL-i f3 gene expression by PCR
Blood was drawn from four patients at several time points
during HD with regenerated cellulose (pre, 5, 15 and 60 mm),
and semiquantitative analysis of IL-1f3 mRNA was performed
by PCR after reverse transcription of I pg RNA into eDNA.
The results of two of these four patients are shown in Figure 4.
PCR using primers specific for /3-actin was performed as an
internal standard; the PCR products for /3-actin became detect-
able after 20 cycles in all samples (data not shown). As shown
in Figure 4, the PCR products for IL-I /3 became detectable after
24 cycles in PBMC sampled pre-I-ID. In cells leaving the
dialyzer at 5 and 60 minutes, the PCR products for IL-1f3
already became detectable after 20 cycles. Since initial experi-
ments revealed an amplification efficiency of 1.8 per cycle, the
observed difference of four cycles reflects a relative increase in
IL-1/3 mRNA of l.8 10-fold in PBMC, leaving the regener-
ated cellulosic dialyzer at 5 and 60 minutes compared to PBMC
sampled pre-HD. However, in all four patients levels of IL-1f3
mRNA were not increased above levels pre-HD in cells leaving
the dialyzer at 15 minutes or in any sample from the afferent
line. In PBMC from normal subjects processed exactly like
those from patients, the PCR products for IL-1$ also became
detectable after 24 cycles.
Change of the PBMC population during HD with regenerated
cellulose
PBMC separated from the afferent and efferent blood samples
analyzed by PCR contained 25 5% esterase-positive cells
pre-HD, 17 2% after five minutes and 4 3% after 15 minutes
after start of HD with regenerated cellulose.
Effect of different dialyzers on IL-I f3 mRNA induction
To evaluate whether the observed increase in IL-l/3 mRNA
was restricted to cellulosic dialyzers, 13 patients were dialyzed
using regenerated cellulose first, and at the next HD session, a
different type of dialyzer was used. Because the maximal
accumulation of IL-1/3 mRNA was consistently observed in
blood samples taken at five minutes from the venous line, we
sampled at this time point. In contrast to regenerated cellulose,
which resulted in readily detectable amounts of IL- 1/3 mRNA at
five minutes, the use of hemophan, polyamide, polysulfone and
polyacrylonitrile resulted in undetectable induction of IL-1/3
mRNA in the same patients (Figs. 5—8).
Plasma levels of C5a were elevated in patients pre-HD
compared to normal controls (Table 1). In the efferent blood
Reg. cellulose-hemophane
Pat. 1
Pat. 2
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Fig. 5. Effect of hemophan on IL -1 /3 mRNA induction. Two different patients were dialyzed using regenerated cellulose and hemophan dialyzers
on two consecutive sessions. Blood was drawn pre-HD and at 5 minutes from the venous outlet, incubated for 30 minutes at 37°C, PBMC were
separated and RNA was extracted. Hybridization for /3-actin was performed on the same blot.
IL-i 13 mRNA Actin mRNA
'0
line, C5a was significantly increased at five minutes after the
start of HD compared to pre-HD with hemophan, polyamide
and polysulfone dialyzers when compared to regenerated cel-
lulose (Table 1).
Correlation of the increases in IL-i f3 mRNA with increases in
C5a levels
Amounts of IL-i (3 mRNA at five minutes after the start of HD
with regenerated cellulose (N = 9), hemophan (N = 3), or
polyamide (N = 4) were determined by laser densitometry and
compared to the amounts present in blood samples taken under
identical conditions during pre-HD. A ratio was calculated by
dividing the densitometric units for the five minute venous
sample by the value for the pre-HD sample, indicating the
relative increase in IL- 1/3 mRNA at five minutes to be above the
levels pre-HD. C5a was measured in the same samples. As
shown in Figure 9, there was a correlation between the increase
in IL-1f3 mRNA and the increase in C5a (r = 0.71, P < 0.01,
Spearman rank correlation).
Effect of anti-C5a on the induction of IL-1f3 mRNA during
HD
To further elucidate the mechanism(s) responsible for accu-
mulation of IL- 1/3 mRNA during HD with regenerated cellu-
lose, in five patients blood leaving a regenerated cellulosic
dialyzer at five minutes after the start of HD was sampled in a
syringe containing a monoclonal antibody directed against
human C5a (12.5 p,g/ml final concentration). Up to concentra-
tions of 100 g!ml, the antibody did not induce IL-1f3 or TNF in
PBMC after 24 hour incubation, nor did it alter endotoxin-
induced cytokine synthesis determined by radioimmunoassay
(data not shown). When anti-human C5a at 12.5 g/ml was
added to blood leaving a regenerated cellulosic dialyzer at five
minutes, the accumulation of IL-i /3mRNA was reduced to 17
10% of the amount of the sample without antibody (P < 0.05,
Fig. 10). As a control, blood was also incubated with mono-
clonal antibodies against human C3a and porcine C3a. In three
experiments, these antibodies did not influence accumulation of
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Schindler et a!: Induction of IL-i f3 mRNA during hemodialysis 717
a . aI I
> >
C)
Fig. 6. Effect ofpolyamide on IL-i 13 mRNA induction. The same patient was dialyzed using regenerated cellulose and polyamide dialyzers on two
consecutive sessions. The figure shows one representative out of four experiments with different patients. Hybridization for /3-actin was performed
on the same blot.
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Fig. 7. Effect of polysulfone on IL-i J3 mRNA induction. The same patient was dialyzed using regenerated cellulose and polysuhfone dialyzers on
two consecutive sessions. LPS denotes PBMC stimulated with 10 nglml LPS for 4 hours as a positive control, normal denotes blood from a normal
subject incubated for 30 minutes at 37°C. The figure shows one representative out of three experiments with different patients.
Fig. 8. Effect of polyacrylonitrile on IL-I /3 mRNA induction. The same patient was dialyzed using regenerated cellulose and polyacrylonitrile
dialyzers on two consecutive sessions. The figure shows one representative out of three experiments with different patients.
IL- 1/3 mRNA significantly (81 and 82% of the amount of IL-i /3
mRNA in the sample without antibody, respectively).
Discussion
The present study demonstrates transcriptional activation of
IL-1f3 in PBMC following a single passage through a regener-
ated cellulosic dialyzer. The observation that the use of regen-
erated cellulosic membranes resulted in more accumulation of
IL-lf3 mRNA at five minutes in the same patient than the use of
membranes (polyacrylonitrile, polysulfone, polyamide and he-
mophan) that activate less complement suggests a role for
complement to trigger IL-1/3 mRNA. Furthermore, an antibody
directed against human C5a added to whole blood sampled five
minutes after the start of RD from the efferent line was able to
reduce the accumulation of IL-1J3 mRNA. This effect was
specific since antibodies against human C3a or porcine C3a had
no significant effect. The concept that C5a is a major factor
contributing to induction of IL- 1/3 transcription during RD
confirms previous observations that in vitro dialysis and recom-
binant C5a is able to trigger transcription of IL-1/3 in vitro [61
and extends our previous studies to in vivo RD.
The maximal accumulation of IL- 1/3 mRNA was observed at
I
Reg. cell.
I I
Polyacrylo-
nitrile
I
I
C))
-1
Ct
E
0z
CI .C CI .CIi)
2
o.
<
tr
>
to 2
>
0 to to
IL-i
mRNA
Schindler et al: Induction of IL-i f3 mRNA during hemodialysis 719
5 minutes
Afferent Efferent
blood blood
Pre-HD line line
ng/ml
Normal controls 2.1 04a
(N = 15)
Reg. cellulose 4.1 0.5 3.9 0.8 28 8•5b(N = 18)
Hemophan 5.7 0.6 ND 12.7 3.4"(N =5)
Polyamide 6.6 1.6 ND 8.5 19b(N=7)
Polysulfone 3.4 0.6 ND 6.4 07b(N =7)
Fold increase in lL-1 mRNA
Fig. 9. Correlation of the increase in IL -1 /3 mRNA with the increase in
C5a levels. Sixteen patients were dialyzed with either regenerated
cellulose (N = 9), polyamide (N = 4) or hemophan (N = 3) dialyzers.
Individual patients who were dialyzed with 2 different types of dialyzers
on consecutive sessions are indicated by the numbers. IL-1/3 mRNA
was quantitated pre-HD and in PBMC leaving the dialyzer 5 minutes
after start of HD by two dimensional densitometry. A ratio 5 minutes
efferent/pre was calculated indicating the relative increase in IL-1f3
mRNA at 5 minutes compared to the amount pre-HD. The increase in
C5a was determined in the same samples and correlated with the
increase in IL-l/3 mRNA (r = 0.71, P < 0.01, Spearman rank
correlation).
Fig. 10. Effect of anti-CSa on the induction of !L-i/3 mRNA. In 5
patients, blood was drawn pre-HD or from the venous blood line of a
regenerated cellulosic dialyzer 5 minutes after start of HD and incu-
bated for 30 minutes at 37°C with and without 12.5 ,ag/ml of a
monoclonal antibody directed against human C5a. PBMC were then
separated, RNA extracted and subjected to Northern analysis. The
specific bands for IL-1f3 were quantitated by two-dimensional densi-
tometry. Data are expressed in % of the densitometric units for the 5
minutes efferent sample without antibody. < 0.05 compared to the
sample without antibody (Wilcoxon signed rank test).
Table 1. CSa levels in normal controls and patients during HD
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Differential counts revealed a substantial reduction in esterase-
positive cells in these cell populations separated from blood
sampled from both the afferent and efferent blood lines at 15
minutes (4 3%) compared to pre-HD (25 5%) and at five
minutes (17 2%). It therefore appears probable that there is a
selective decrease in peripheral monocyte count while the
lymphocyte count is less influenced, as demonstrated previ-
ously [291. Thus, as lymphocytes are poor IL-i producers
compared to monocytes [30], the failure to detect mRNA in the
15 minute PBMC samples is due to a basic deficiency in
monocytes even in the presence of maximal concentrations of
C5a. At later time points after the start of HD with regenerated
ir. cellulose (1 and 3 hours) there was less induction of IL-113
100 mRNA, although cell numbers were up to pre-HD levels or
even above [29]. However, at these time points there was less
complement activated by the membrane compared to 5 or 15
minutes, probably due to the coating of the membrane with
plasma constituents [31].
In the present study, IL-1f3 mRNA was detected above
pre-HD levels only in cells leaving the dialyzer. At five minutes
after the start of HD, only a fraction (—1 liter) of the total
amount of blood had been circulated through the dialyzer;
therefore, the activated cells in afferent blood (those that had
been passed through the dialyzer) might have been too diluted
to detect. However, at three hours after the start of HD when
all circulating mononuclear cells would have been passed
through the dialyzer, PBMC from the afferent blood line still did
not express increased amounts of IL-1j3 mRNA. An alternative
explanation could be that the 30-minute incubation time of
whole blood might have overestimated the degree of IL-1f3
mRNA induction, since the PBMC would have been exposed to
the activated complement factors for a longer time than in vivo.
At blood flow rates of 200 mllmin, the time from the effluent
blood leaving the dialyzer until it is diluted in the central venous
five minutes after start of HD. Fifteen minutes after start of HD,
when complement activation was maximal, we were unable to
obtain sufficient amounts of RNA for Northern analysis. We
therefore employed the more sensitive PCR; even then, no
increases in IL-l/3 mRNA in cells entering or leaving the
dialyzer were observed at this time point compared to pre-HD.
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pooi could not exceed two minutes. To resolve this problem, we
exposed blood from four normal donors to recombinant C5a for
different time intervals. Even when blood was exposed to 30
nglml C5a for only two minutes and then diluted to 5 ng/mI for
a further 28-minute incubation period, we observed induction of
IL-l/3 mRNA, although less than when 30 ng/ml C5a was
present for the whole incubation period. Therefore, in vivo the
induction of IL-113 mRNA may be less, but might still occur
with shorter exposure times. In addition, increased amounts of
IL-l/3 mRNA could still be detected in blood samples leaving
the regenerated cellulosic dialyzer after three hours. As acti-
vated PBMC were not present in the afferent blood at three
hours despite of sufficient time for them to recirculate through
the dialyzer, it seems reasonable to postulate that activated
cells leave the circulation and do not return during the dialysis
session. This does not imply that PBMC leave the circulation
because they express IL-1f3 mRNA, but rather there is a
common stimulus for transcription of IL-1J3 and cell adhesive-
ness. These activated cells may (1) enter the peripheral margin-
ating pool, or (2) be sequestered in the lung as the first capillary
bed behind the dialyzer [32]. At later time points, they may
either translate their mRNA or degrade it. If they translate their
mRNA, they may release IL-i from the lung. In cases where
these activated cells might enter the muscle tissue, IL-l pro-
duction could contribute to muscle catabolism induced by the
dialysis procedure [3, 4], since the combination of IL-i and
TNF had been shown to increase muscle proteolysis in vivo [33,
34]. Pre-HD, IL-lf3 mRNA was not elevated compared to
normal subjects, suggesting that PBMC pre-HD had not been
circulating during the previous session or had already degraded
their pool of IL-l/3 mRNA.
In some previous studies, plasma levels of C5a were reported
to be higher than in the present study [31]. These differences
probably reflect different assay procedures since most of the
described antibodies against C5a recognize the precursor pro-
tein C5 as well [28]. CS had to be removed from plasma by
different precipitation procedures before assaying C5a. Our C5a
levels were measured using specific antibodies against C5a that
do not cross react with C5; consequently, the C5a levels in the
present study are lower than in most previous reports. Our
finding of elevated plasma levels of C5a in HD patients com-
pared to normal subjects confirms previous observations [31,
35].
Until now, it has been difficult to prove induction of cyto-
kines by HD in vivo. The present study demonstrates transcrip-
tion of IL-1/3 during in vivo HD with regenerated cellulosic
dialyzers. This observation may be applied for investigating the
biocompatibility of dialyzers and may help in understanding
chronic complications of the dialysis procedure.
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